Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aurora A kinase is a novel therapeutic target in the myeloproliferative neoplasms
    Meeting Abstract

    Wen, Q. J.; Goldenson, B.; Malinge, S.; Stein, B. L.; Lasho, T. L.; Breyfogle, L.; Schultz, R.; Yang, Q.; Gilles-Gendre, L.; Koppikar, P.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Arginine methylation of RBM15 by PRMT1 controls alternative splicing of genes involved in megakaryocyte differentiation
    Meeting Abstract

    Zhao, X.; Zhang, L.; Wang, R.; Trans, N. T.; Su, H.; Abdel-Wahab, O.; Hrick, T.; Levine, R. L.; Deng, H.; Liu, Y.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Increased incidence of melanoma and non-melanoma skin cancers in patients with hairy cell leukemia: A single institution experience with 267 patients from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Watts, J. M.; Kishtagari, A.; Devlin, S.; Stein, E. M.; Park, J. H.; Lacouture, M. E.; Tallman, M.
    Blood (2013)

    Fulltext@MSK | Save
  • Comprehensive mutational profiling in myelodysplastic syndromes treated with decitabine and tretinoin
    Meeting Abstract

    Shih, A. H.; Devlin, S. M.; Dolezal, E. K.; Knapp, K. M.; Wang, K.; Sanford, E. M.; Brennan, T.; Yelensky, R.; Nahas, M.; Otto, G. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Epigenetic profiling of leukemia stem cells in a model of TET2/FLT3-mutant AML
    Meeting Abstract

    Shih, A. H.; Jiang, Y.; Shank, K.; Pandey, S.; Viale, A.; Sun, Y.; Socci, N.; Robertson, A.; de Stanchina, E.; Hricik, T.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Azacitidine with or without entinostat for the treatment of therapy-related myeloid neoplasm: Further results of the E1905 North American Leukemia Intergroup Study
    Meeting Abstract

    Prebet, T.; Sun, Z.; Ketterling, R.; Greenberg, P. L.; Zeidan, A. M.; Litzow, M. R.; Gabrilove, J. L.; Erba, H. P.; Paietta, E.; Czader, M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Integrated genetic profiling of JAK2 wildtype chronic-phase myeloproliferative neoplasms
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; Patel, J. P.; Knapp, K. M.; Patel, M.; Greenbowe, J. R.; Young, L. E.; He, J.; Wang, K.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; RivieĢ€re, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • A bi-specific T cell engaging monoclonal antibody (mAb) derived from a TCR-Like mAB specific for WT1/HLA-A0201 (ESK-BiTE) shows a potent activity against human AML and Ph+ ALL in mouse models
    Meeting Abstract

    Pankov, D.; Dao, T.; Wang, Y.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Veomett, N.; Curcio, M.; Doubrovina, E.; O'Reilly, R. J.; more...
    Blood (2013)

    Fulltext@MSK | Save